Drug intelligence / Profile preview

fluticasone propionate

Development stage
Approved
Lead developer
GSK
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Inhalation, Intranasal, Topical
01

Overview

Fluticasone propionate is a synthetic glucocorticoid steroid medication used primarily for its anti-inflammatory effects. It is available in various formulations including inhalers (for asthma and chronic obstructive pulmonary disease), nasal sprays (for allergic rhinitis and nasal polyps), and topical creams (for skin conditions such as eczema and psoriasis). The drug works by activating glucocorticoid receptors to suppress inflammation through multiple pathways. It was first patented in 1980 and approved for medical use in 1990. Fluticasone propionate is widely prescribed globally and is available as both branded and generic products[4][5].

Brand names
FloventFlonaseAdvairAirduoAirduo RespiclickAller-floArmonairBeserCutivateDymistaFluticareTicanaseWixelaXhance
Other names
fluticasone propionate inhalation aerosolfluticasone propionate HFA
02

Targets

MR (Mineralocorticoid receptor)GR (Glucocorticoid receptor)PLA2G4A (Cytosolic phospholipase A2 alpha)PR (Progesterone receptor)Kv1 (Voltage-gated potassium channel subfamily A)

Beyond the preview

Go deeper on fluticasone propionate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluticasone propionate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call